35.71
Kiniksa Pharmaceuticals International Plc Azioni (KNSA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
13.80%
156.80
|
137.78 | 122.54 | 112.21 | 108.63 |
Cost Of Revenue |
4.11%
18.60
|
17.87 | 17.90 | 20.11 | 12.32 |
Gross Profit |
15.24%
138.19
|
119.92 | 104.64 | 92.11 | 96.31 |
|
10.68%
118.03
|
106.64 | 123.94 | 101.76 | 96.43 |
Benefits Costs and Expenses |
9.57%
133.92
|
122.22 | 139.51 | 119.42 | 106.33 |
Costs And Expenses |
9.57%
133.92
|
122.22 | 139.51 | 119.42 | 106.33 |
Depreciation and Amortization |
3.77%
0.358
|
0.345 | 0.40 | 0.399 | 0.43 |
Operating Income/Loss |
51.90%
20.16
|
13.27 | -19.30 | -9.658 | -0.117 |
Income/Loss From Continuing Operations Before Tax |
46.98%
22.88
|
15.56 | -16.98 | -7.201 | 2.304 |
Income Tax Expense/Benefit, Deferred |
11.66%
2.644
|
2.993 | -3.163 | -3.639 | 10.57 |
Income Tax Expense/Benefit |
28.20%
5.045
|
7.026 | -8.091 | 5.492 | 6.212 |
Income/Loss From Continuing Operations After Tax |
108.83%
17.83
|
8.539 | -8.888 | -12.69 | -3.908 |
|
108.83%
17.83
|
8.539 | -8.888 | -12.69 | -3.908 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1.09%
73.44
|
72.65 | 0.3005 | 71.73 | 71.00 |
Diluted Average Shares |
2.36%
77.94
|
76.15 | 0.3005 | 71.73 | 71.00 |
Basic Earnings Per Share |
100.00%
0.24
|
0.12 | -0.12 | -0.18 | -0.06 |
Diluted Earnings Per Share |
109.09%
0.23
|
0.11 | -0.12 | -0.18 | -0.06 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):